Lucid Diagnostics Inc. cotiza a 0.60 USD y tiene una capitalización bursátil de $114M. En los últimos 12 meses ha facturado $5M con un margen de flujo de caja libre del -992.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship p…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.07 | $-0.10 |
| Estimado | $-0.06 | $-0.05 | $-0.06 | $-0.09 |
| Sorpresa | — | — | -16.7% | -11.1% |
| Métrica | LUCD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -41.7% | 57.0% | -98.8% |
| Operating Margin | -1054.8% | -38.6% | -1016.2% |
| Net Margin | -1232.7% | -33.6% | -1199.1% |
| FCF Margin | -992.0% | -13.9% | -978.1% |
| ROE | -530.5% | -40.4% | -490.1% |
| ROA | -143.4% | -32.0% | -111.4% |
| Current Ratio | 1.31 | 2.84 | -1.53 |
| Debt / Equity | — | 0.28 | — |